409 results on '"Gavasso, S"'
Search Results
102. Similar hypercoagulable state and thrombosis risk in type I and type III proteinS-deficient individuals from mixed type I/III families
103. Circulating endothelial and apoptotic micropaticles in Cynomolgus Monkeys after xenograft
104. Decrease factor VIIA/antithrombin complexes in children with ischemic stroke
105. Xenotransplantation and coagulation disorders: different levels of human activated protein C in human and porcine endothelial cells
106. Endogenous Thrombin Potential (ETP) in 22 pregnant women
107. Preliminary study in a life supporting pig to primate xenotransplantation model using GAL KO pigs transgenic for human CD39, CD55, CD59 and fucosyltransferase
108. Type III protein S deficiency is associated with a hypercoagulable state and an increased risk of venous thrombosis
109. Whole blood thromboelastometry in human and cynomolgus monkeys
110. Microparticles plasma levels in patients with venous thromboembolism and cancer
111. Comparison of procoagulant phospholipids levels between human and cynomolgus monkeys
112. Hypercoagulable whole blood rotation thromboelastometry (ROTEM®) profile in 40 cynomolgus monkeys
113. Synthesis of protein s by human megakaryocytes
114. HYPOFIBRINOLYSIS DUE TO INCREASE TAFIa PLASMA LEVELS IN CANCER PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM
115. Increased thrombin generation during pregnancy
116. PROCOAGULANT PHOSPHOLIPIDS ACTIVITY IN CANCER PATIENTS WITH VENOUS THROMBOEMBOLISM
117. Direct correlation between platelet and plasma factor V levels in homozygous and heterozygous factor V deficient subjects
118. Thrombin generation in patients with severe factor V deficiency relies on platelet factor V
119. Comparison of thrombin generation between humans and cynomolgus monkeys
120. Coagulation profile in cynomolgus monkey recipients of porcine neuronal xenograft: a preliminary study
121. Hypofibrinolysis in patients with venous thromboembolism and cancer
122. PLASMA AND PLATELET PROTEIN S ANTIGEN LEVELS IN PATIENTS UNDER TREATEMENT WITH WARFARIN
123. Platelet protein S antigen levels in congenital protein S deficiency
124. Procoagulant phospholipids in patients with venous thromboembolism and cancer
125. Microparticles plasma levels in women with venous thromboembolism and cancer
126. Activation of human protein C by a1,3-galactosyltransferase gene-knockout porcine aortic endothelial cells ex pressing human thrombomodulin
127. Decreased levels of platelet protein S in patients under treatment with warfarin
128. Evidence of the first X-linked thrombophilia due to a novel mutation in clotting factor IX gene resulting in hyperfunctional fix: factor IX arginine 338 leucine (factor IX padua)
129. Venous thromboembolism and antiphospholipids antibodies toward protein C/protein S system: a case control study
130. Whole blood rotation thromboelastometry (ROTEM®) profile in 40 cynomolgus monkeys
131. PLASMA AND INTRA-PLATELET FACTOR V ANTIGEN LEVELS IN FACTOR V DEFICIENT SUBJECTS
132. Comparison of whole blood coagulation assessment using thromboelastometry (ROTEM®) between human and cynomolgus monkeys
133. Increased endogenous thrombin potential (ETP) in carriers of inherited clotting inhibitors defects
134. Decrease factor VIIa/antithrombin complexes in 31 subjects belonging to 7 families with FVII deficiency
135. Increased Endogenous Thrombin Potential (ETP) in patients of families with inherited AT defects
136. Riduzione dei livelli plasmatici del complesso FVIIa/AT nei pazienti con trombosi arteriosa acuta: un possibile nuovo meccanismo eziopatogenetico
137. Immunological characterization of the Prothrombinase Complex and Protein C anticoagulant pathway in primates and pigs
138. Study on the origin of coagulation protein S in human megakaryocyte cultures and caractherization of platelets protein S from patients with inherited protein S deficiency
139. Decrease factor VIIa/antithrombin complexes in patients with venous thromboembolism: a new insight in the pathogenetic mechanism
140. Coagulation profiles in primate recipients of porcine kidneys exposed to long-term treatment with recombinant activated protein C
141. Effect of APC resistence associated with factor V mutation on plasma fibrinolysis
142. Recombinant human activated protein C (rh APC) in pig-to-primate xenotransplantation: results of a preliminary study
143. Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT)
144. O32 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC ALTERATIONS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
145. OC.04.1 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC STATUS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
146. Hemostatic status and portal vein thrombosis (PVT) in cirrhotic patients with hepatocellular carcinoma (HCC)
147. Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis
148. Predictive value of antithrombin III Levels on the outcome of a porcine renal xenografts trasplanted primated
149. Value of protein C and protein S levels for predicting the outcome of porcine renal xengrafts transplanted into primates
150. Anti-thrombin III levels in cynomolgus monkey recipients of life-supporting porcine renal xenograft
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.